Impact of Optimum Patient Care’s clinical review service (Impact of OPC)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/33440
• EU PAS number:
  EUPAS14111
• Study ID:
  33440
• Official title and acronym:
  Impact of Optimum Patient Care’s clinical review service (Impact of OPC)
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  Historical cohort study evaluating the impact of a remote annual asthma clinical review service on high risk asthma patients in a UK primary care setting. Optimum Patient Care (OPC) is a social enterprise company whose aim is to improve patient outcomes in respiratory medicine through continuous audit and feedback to practices at a practice and individual patient level. OPC offers a free and unique remote clinical review service to support management of patients in primary care, using the company’s bespoke software tools. OPC provides practices with patient-specific reports including suggestions for interventions in accord with current asthma guidelines. These recommendations include identification of patients at high-risk of exacerbations and of patients who are seemingly on inappropriate medication and require urgent attention.The purpose of this study is to evaluate, for the first time, the impact that OPC’s review service has on patients’ primary care utilisation, treatment and asthma exacerbation frequency. The analysis will focus on patients who are deemed high risk based on their exacerbation history.The data extracted from practices by OPC enters their service database and is used to create patient-specific recommendations to the practice. It is also anonymized for use in respiratory research. This database, cleared of all patient identifiable information, is called the Optimum Patient Care Research Database (OPCRD) and will be used in this study.
• Study status:
  Planned

Research institutions and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Study timelines

Date when funding contract was signed

Actual: 01/03/2016

Study start date

Planned: 01/08/2016

Data analysis start date

Planned: 01/09/2016

Date of final study report

Planned: 26/02/2021

Sources of funding

Other

More details on funding

Optimum Patient Care

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable